Table 1

Mutation prevalence in 506 de novo DLBCL patients treated with R-CHOP

No. of patientsPrevalenceNo. of mutationsNo. of mutation variants
Total patients 506  133 99 
Patients with WT-TP53* 395 78% 
Patients with MUT-TP53 111 22% 132 98 
    Patients with missense mutations 92 18.2% 107 79 
    Patients with nonsense mutations 14 2.8% 14 
    Patients with a 2-bp deletion causing reading frame shift 0.4% 
    Patients with silent mutations§ 0.6% 
    Patients with a mutation at the splicing sites 1.4% 
No. of patientsPrevalenceNo. of mutationsNo. of mutation variants
Total patients 506  133 99 
Patients with WT-TP53* 395 78% 
Patients with MUT-TP53 111 22% 132 98 
    Patients with missense mutations 92 18.2% 107 79 
    Patients with nonsense mutations 14 2.8% 14 
    Patients with a 2-bp deletion causing reading frame shift 0.4% 
    Patients with silent mutations§ 0.6% 
    Patients with a mutation at the splicing sites 1.4% 
*

One DLBCL patient with only 1 silent mutation is also counted as WT-TP53.

Seventeen DLBCL patients had multiple (2-4) mutations.

Fifteen DLBCL patients had 2 missense mutations.

§

These 2 patients also carried missense mutations.

Four patients carrying a mutation at the splicing site also carried missense mutations.

Close Modal

or Create an Account

Close Modal
Close Modal